InVision Precision Cardiac Amyloid vs Vivid S60N

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by InVision Medical Technology
VS
by GE HealthCare Technologies Inc

AI Verdict

Tool A is a specialized AI-powered software designed for the specific detection of cardiac amyloidosis from echocardiogram studies. In contrast, Tool B is a comprehensive AI-enabled cardiovascular ultrasound system, providing advanced imaging capabilities and general automated measurements. While both operate in the cardiology AI space, Tool A offers a targeted diagnostic aid that could complement the broader imaging and workflow enhancements provided by a system like Tool B.

Choose InVision Precision Cardiac Amyloid if…

Choose InVision Precision Cardiac Amyloid if your primary goal is to specifically enhance the early detection and reduce misdiagnosis of cardiac amyloidosis within your existing echocardiography workflow. This AI-powered software is designed to integrate seamlessly as a Software as a Medical Device (SaMD) to aid clinicians in identifying this often underdiagnosed, life-threatening condition. It is ideal for practices seeking a specialized tool focused solely on improving outcomes for patients with suspected AL or ATTR Cardiac Amyloidosis.

View InVision Precision Cardiac Amyloid →

Choose Vivid S60N if…

Choose GE HealthCare Vivid S60N if your facility requires a comprehensive, state-of-the-art cardiovascular ultrasound system capable of performing a wide range of advanced cardiac imaging and diagnostics. This on-premise medical device offers AI-enabled automation for general measurements and workflow efficiency, exceptional image quality across 2D and 4D imaging, and robust quantification tools for various heart functions and valve anatomies. It is best suited for practices needing a versatile, high-performance ultrasound platform for broad cardiology, pediatrics, and radiology applications.

View Vivid S60N →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature InVision Precision Cardiac Amyloid Vivid S60N
Pricing Unknown Contact vendor for pricing
Deployment Cloud or on-premise On-premise (physical medical device)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

InVision Precision Cardiac Amyloid

Tool A, as a Software as a Medical Device (SaMD), is designed to integrate directly into existing clinical workflows for echocardiography labs, which generally implies less disruption and easier adoption for its specific diagnostic function. In contrast, Tool B is a complete physical ultrasound system, requiring a larger infrastructure change, despite its ergonomic design and workflow enhancements.

Clinical Value

InVision Precision Cardiac Amyloid

Tool A offers a highly specific and impactful clinical value by addressing the critical and often-missed diagnosis of cardiac amyloidosis, with its AI algorithm being peer-reviewed and published in a prestigious journal like JAMA Cardiology. While Tool B provides broad enhancements to cardiovascular ultrasound, Tool A's targeted approach to an underdiagnosed, life-threatening condition demonstrates a more distinct and significant clinical contribution.

Pricing & Value

InVision Precision Cardiac Amyloid

Tool A provides a clear, transparent, and accessible subscription pricing model starting at $49/month, making its value proposition more predictable and potentially more affordable for a wider range of users or smaller practices. Tool B, as a comprehensive medical device, has opaque and likely significantly higher costs, which can be a barrier to adoption.

Enterprise Readiness

Vivid S60N

As a comprehensive medical device from a major healthcare technology vendor like GE HealthCare, Tool B is inherently built for deep integration into existing hospital IT infrastructure, including PACS and EMR systems, and comes with the robust support and established processes expected in enterprise deployments. While Tool A is also FDA cleared and HIPAA compliant SaMD, Tool B's nature as a foundational piece of equipment from a global leader provides a higher degree of enterprise readiness.

Innovation

InVision Precision Cardiac Amyloid

Tool A demonstrates a more focused and impactful innovation by applying AI to specifically detect cardiac amyloidosis, a life-threatening and often underdiagnosed condition, with its algorithm validated through peer-reviewed research. While Tool B offers broad AI enhancements to general ultrasound imaging, Tool A's targeted solution for a critical diagnostic challenge represents a more distinct and specialized innovation.

Support & Docs

Vivid S60N

GE HealthCare (Tool B) clearly outlines a comprehensive support ecosystem, including unlimited remote expert live support, an online community, and various educational resources, ensuring robust assistance throughout the product's lifecycle. InVision Medical Technology (Tool A), while having strong scientific backing, does not provide comparable explicit details regarding its customer support infrastructure or extensive documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature InVision Precision Cardiac Amyloid Vivid S60N
Tool Name InVision Precision Cardiac Amyloid Vivid S60N
Company InVision Medical Technology Corporation GE HealthCare
Description AI-powered software for echocardiography to detect cardiac amyloidosis, a life-threatening and often underdiagnosed disease, aiming for earlier detection and improved patient outcomes. The GE HealthCare Vivid S60N and S70N are advanced cardiovascular ultrasound systems featuring AI-powered imaging, automated measurements, and workflow enhancements for confident diagnosis and efficient patient care.
Primary AI Application AI-powered detection of cardiac amyloidosis; Aids clinicians in diagnosing and assessing patients with heart failure symptoms. AI-enabled automation for measurements and workflow; AI-powered imaging.
Target Specialties Cardiology, Radiology Cardiology, Pediatrics, Radiology
Specific Imaging/Workflow Focus Evaluation of transthoracic echocardiogram studies (apical-4-chamber and parasternal-long-axis view videos); Precise assessment of wall thickness in parasternal long axis view. Advanced 2D and 4D ultrasound imaging capabilities; Advanced quantification tools for heart function and valve anatomy; DICOMu00ae connectivity.

Videos

Demos, reviews, and walkthroughs featuring InVision Precision Cardiac Amyloid and Vivid S60N.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

InVision Precision Cardiac Amyloid is an AI-powered software specifically designed for the detection of cardiac amyloidosis (both AL and ATTR types) from existing echocardiogram studies, aiming for earlier diagnosis and reduction of misdiagnosis. The GE HealthCare Vivid S60N is an advanced cardiovascular ultrasound system that provides AI-enabled automation for general measurements and workflow enhancements, alongside advanced 2D and 4D ultrasound imaging capabilities for a broad range of cardiac assessments.
InVision Precision Cardiac Amyloid offers AI-powered detection of cardiac amyloidosis by evaluating transthoracic echocardiogram videos and performing precise assessment of wall thickness. The GE HealthCare Vivid S60N provides AI-enabled automation for measurements and workflow, including automated Cardiac Auto-Doppler and 2D-LV measurements, to improve efficiency and reproducibility.
InVision Precision Cardiac Amyloid's AI algorithm is evidence-based, peer-reviewed, and published in JAMA Cardiology, with further validation showing no racial bias and confirmation of accuracy in clinical trial data. The GE HealthCare Vivid S60N emphasizes exceptional image quality through cSoundu2122 software beamformer technology and advanced quantification tools for heart function and valve anatomy, with AI-based measurement tools reducing exam time and increasing accuracy.
InVision Precision Cardiac Amyloid is designed to aid clinicians in diagnosing and assessing patients with heart failure symptoms for AL and ATTR Cardiac Amyloidosis, including early detection even before heart failure symptoms. The GE HealthCare Vivid S60N is a versatile cardiovascular ultrasound system applicable across cardiology, pediatrics, and radiology for various heart function and valve anatomy assessments.
AI Tool Finder
AI-powered search. Results may not be comprehensive.